首页> 外文OA文献 >P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine

【2h】

P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine

机译：P052。患者对皮下注射双氯芬酸钠HPβCD（25 mg / mL）溶液的易用性，起效速度，疗效和耐受性的主观判断，而口服口服双氯芬酸钾50 mg用于急性偏头痛的治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine [J] . Maurizio Evangelista, Francesco Maria Piseddu The journal of headache and pain . 2015,第1期

机译：P052。患者对皮下注射双氯芬酸钠HPβCD（25 mg / mL）溶液的易用性，起效速度，疗效和耐受性的主观判断，与口服口服双氯芬酸钾50 mg用于急性治疗偏头痛
2. P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine [J] . Maurizio Evangelista, Francesco Maria Piseddu The journal of headache and pain . 2015,第1期

机译：P052。患者对皮下注射双氯芬酸钠HPβCD（25 mg / mL）溶液的易用性，起效速度，疗效和耐受性的主观判断，与口服口服双氯芬酸钾50 mg用于急性治疗偏头痛
3. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT). [J] . Lipton RB, Grosberg B, Singer RP, Cephalalgia . 2010,第11期

机译：新粉末制剂的疗效和耐受性对偏头痛急性治疗的口服溶液的疗效和耐受性：国际偏头痛评估临床试验（影响）的结果。
4. P052. Patients subjective judgement on the ease of use speed of onset of action efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine [O] . Maurizio Evangelista, Francesco Maria Piseddu 2015

机译：P052。患者对皮下注射双氯芬酸钠HPβCD（25 mg / mL）溶液的易用性起效速度疗效和耐受性的主观判断而口服口服双氯芬酸钾50 mg用于急性偏头痛的治疗
5. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine [O] . Evangelista, Maurizio, Piseddu, F 2015

机译：患者对皮下注射双氯芬酸钠HPβCD（25 mg / mL）溶液的易用性，起效速度，疗效和耐受性的主观判断，而口服口服双氯芬酸钾50 mg用于急性偏头痛的治疗

P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine

著录项

相似文献

相关主题

期刊订阅